Liquid chromatography–tandem mass spectrometry for the simultaneous quantitation of artemether and lumefantrine in human plasma: Application for a pharmacokinetic study

详细信息    查看全文

• 作者：Isabela Costa Cé ; sar ; José ; Antô ; nio de Aquino Ribeiro ; Leonardo de Souza Teixeira ; Karini Bruno Bellorio ; Fern ; a Crunivel de Abreu ; Josianny Mesquita Moreira ; Paula Rocha Chellini ; Gerson
• 关键词：Artemether ; Lumefantrine ; HPLC– ; ESI– ; MS/MS ; Plasma ; Pharmacokinetics
• 刊名：Journal of Pharmaceutical and Biomedical Analysis
• 出版年：2011
• 出版时间：5 January 2011
• 年：2011
• 卷：54
• 期：1
• 页码：114-120
• 全文大小：702 K

文摘

A liquid chromatography–electrospray ionization tandem mass spectrometry (HPLC–ESI-MS/MS) method for the simultaneous quantitation of artemether and lumefantrine in human plasma was developed and validated. Artesunate was used as an internal standard (IS). The analytes were extracted by a protein precipitation procedure and separated on a reversed-phase Zorbax SB-Ciano column with a mobile phase composed of methanol and 10 mM aqueous ammonium acetate containing 0.2 % (v/v) acetic acid and 0.1 % (v/v) formic acid. Multiple reaction monitoring was performed using the transitions m/z 316 → m/z 267, m/z 530 → m/z 348 and m/z 402 → m/z 267 to quantify artemether, lumefantrine and artesunate, respectively. Calibration curves were constructed over the range of 10–1000 ng/mL for artemether and 10–18,000 ng/mL for lumefantrine. The lower limit of quantitation was 10 ng/mL for both drugs. The mean R.S.D. values for the intra-run precision were 2.6 % and 3.0 % and for the inter-run precision were 3.6 % and 4.6 % for artemether and lumefantrine, respectively. The mean accuracy values were 102.0 % and 101.2 % for artemether and lumefantrine, respectively. No matrix effect was detected in the samples. The validated method was successfully applied to determine the plasma concentrations of artemether and lumefantrine in healthy volunteers, in a one-dose pharmacokinetic study, over the course of 11 days.